Quality-of-life support after cardioversion for persistent AF
Part of Heart & circulation clinical trials.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have persistent atrial fibrillation (AF).
- Your AF symptom burden (how much it affects you) is not yet well known.
- You do NOT have a known blood clot in the left atrial appendage (a clot risk area in the heart).
- You have NOT had prior AF ablation by catheter or surgery.
- You can take the usual blood thinners safely, and you do NOT have an allergy or medical reason you cannot take amiodarone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
This trial compares two ways of doing cardioversion (a procedure to restore normal heart rhythm) for people with persistent atrial fibrillation. It aims to see if one approach leads to a better recovery and fewer complications.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This study looks at whether giving an electrical shock (cardioversion) right after heart surgery can help people with long-lasting atrial fibrillation keep a normal heartbeat. It may help guide future treatment decisions for patients who have not gotten better with medication.
This study compares different ways of doing a procedure called catheter ablation to treat a type of atrial fibrillation that lasts longer than 7 days. They want to see if adding an extra step to the standard treatment helps more than just doing the standard treatment alone. If you join, you will be randomly assigned to one of the three treatment groups.
This trial tests a special defibrillation technique that uses two shocks to reset the heart's rhythm in people with persistent atrial fibrillation. It aims to help patients regain a normal heartbeat without the need for more invasive procedures.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.